GlassScriptPhysician profile
Raquel A Garcia
NPI 1164033965
$8,082.10
in general payments reported to CMS, 2019-2025
33 companies · $2,141 in 2025
The $2,141 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $578 · 2022: $1,432 · 2023: $2,032 · 2024: $1,899 · 2025: $2,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,719 · Consulting Fee: $200 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,719.29 |
| Consulting Fee | $200.00 |
| Education | $152.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,274.17 | 2021-2025 | Tezspire, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,185.91 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Electromed, INC. | $1,103.21 | 2022-2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $885.84 | 2021-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Philips North America LLC | $386.71 | 2022-2025 | Vest Therapy Und, (8874) Incourage |
| Axsome Therapeutics, INC. | $383.35 | 2023-2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $351.61 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $316.15 | 2022-2024 | |
| Galderma Laboratories, L.P. | $284.52 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $260.02 | 2023-2025 | Dupixent |
| Amgen INC. | $194.04 | 2023-2025 | Tezspire |
| Baxter Healthcare | $165.29 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Redhill Biopharma INC. | $148.72 | 2024 | Talicia |
| Mayne Pharma Commercial LLC | $133.76 | 2021-2022 | |
| Inspire Medical Systems, INC. | $127.36 | 2023 | Inspire |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $115.42 | 2024-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $114.97 | 2021-2025 | |
| Mylan Specialty L.P. | $114.75 | 2022-2023 | Yupelri |
| Verona Pharma, INC. | $84.42 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $79.99 | 2023 | |
| Janssen Pharmaceuticals, INC | $54.91 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $46.35 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $42.85 | 2022 | |
| Insmed, INC. | $37.26 | 2023 | Arikayce |
| Lilly USA, LLC | $32.97 | 2025 | Zepbound, Mounjaro |
| Vanda Pharmaceuticals INC. | $26.27 | 2022 | |
| Vifor Pharma, INC. | $23.55 | 2025 | Zemaira |
| Harmony Biosciences LLC | $22.83 | 2025 | |
| Fisher & Paykel Healthcare INC | $19.52 | 2025 | Fisher & Paykel Healthcare |
| Agile Therapeutics, INC. | $19.19 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.25 | 2025 | Nuzyra |
| Breas Medical, INC. | $14.39 | 2023 | Vivo 45 Ls |
| Pulmonx Corporation | $13.55 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raquel Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.